We are live on ! Find out more
AMAG

AMAG Pharmaceuticals
AMAG

Delisted

AMAG was delisted on the 13th of November, 2020.

Back to rankings

187 hedge funds and large institutions have $774M invested in AMAG Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 68 increasing their positions, 54 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 20

26% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 54

7% more funds holding

Funds holding: 174 → 187 (+13)

3% less capital invested

Capital invested by funds: $802M → $774M (-$28M)

76% less call options, than puts

Call options by funds: $3.87M | Put options by funds: $16.4M

Holders
187
Holders Change
+13
Holders Change %
+7.47%
% of All Funds
4.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
35
Increased
68
Reduced
54
Closed
20
Calls
$3.87M
Puts
$16.4M
Net Calls
-$12.5M
Net Calls Change
-$3.13M

Top Buyers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
+$17.7M
2
PP
PDT Partners
New York
+$5.47M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.45M
4
TAM
Tocqueville Asset Management
New York
+$4M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.99M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$25.5M
2
Citadel Advisors
Citadel Advisors
Florida
-$21.7M
3
GAM
Gotham Asset Management
New York
-$6.87M
4
State Street
State Street
Massachusetts
-$6.1M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$6.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
HR
176
Howe & Rusling
New York
$3K – – –
Loomis, Sayles & Company
177
Loomis, Sayles & Company
Massachusetts
$3K – – –
AIM
178
Advantage Investment Management
Iowa
$2K – – –
Envestnet Asset Management
179
Envestnet Asset Management
Illinois
$2K – – –
AG
180
Advisor Group
Arizona
$1K -$6.13K -329 -92%
PA
181
Parallel Advisors
California
$1K – – –
TWA
182
TCI Wealth Advisors
Arizona
$1K +$913 +49 New
LWCFA
183
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$1K +$1.16K +62 New
Walleye Trading
184
Walleye Trading
New York
$460 +$364K +19,519 +361%
Citadel Advisors
185
Citadel Advisors
Florida
– -$21.7M -1,164,079 Closed
American Century Companies
186
American Century Companies
Missouri
– -$3.85M -209,192 Closed
AC
187
Ascend Capital
California
– -$3.04M -165,476 Closed
UONDDL
188
University of Notre Dame du Lac
Indiana
– -$2.27M -123,140 Closed
KBC Group
189
KBC Group
Belgium
– -$1.51M -81,910 Closed
CEP
190
Chicago Equity Partners
Illinois
– -$1.29M -70,180 Closed
Wellington Management Group
191
Wellington Management Group
Massachusetts
– -$957K -52,037 Closed
RCAMU
192
Rothschild & Co Asset Management US
Connecticut
– -$738K -40,132 Closed
Los Angeles Capital Management
193
Los Angeles Capital Management
California
– -$542K -29,458 Closed
ARTA
194
A.R.T. Advisors
New York
– -$447K -24,306 Closed
NIPH
195
NN Investment Partners Holdings
Netherlands
– -$343K -18,640 Closed
SG Americas Securities
196
SG Americas Securities
New York
– -$319K -17,320 Closed
PCM
197
Piermont Capital Management
Missouri
– -$233K -12,670 Closed
FRM
198
Fox Run Management
Connecticut
– -$226K -12,300 Closed
GIA
199
Gargoyle Investment Advisor
New Jersey
– -$186K -10,127 Closed
AIM
200
Acrospire Investment Management
Illinois
– -$63K -3,400 Closed
5 6 7
8
9

AMAG Hedge Fund Activity: Q3 2017 in Review

187 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q3 2017, worth a combined $774M — down 3.5% from $802M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new AMAG positions and 20 closed out — a net gain of 15 holders — while 68 added to existing stakes and 54 trimmed.

The largest buyer was Camber Capital Management, adding an estimated $17.7M. The largest seller was Invesco, cutting an estimated $25.5M.

  • 187 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q3 2017, up from 174 in Q2 2017.
  • Funds reported $774M of AMAG Pharmaceuticals stock for Q3 2017, down 3.5% quarter-over-quarter.
  • 35 funds opened new AMAG Pharmaceuticals positions in Q3 2017 and 20 closed out, a net change of +15 holders.
  • The largest AMAG Pharmaceuticals buyer in Q3 2017 was Camber Capital Management, an estimated $17.7M added.
  • The largest AMAG Pharmaceuticals seller in Q3 2017 was Invesco, an estimated $25.5M sold.

Based on aggregated 13F filings for Q3 2017.